Global Cancer Biological Therapy Market Size, Status and Forecast 2022

August 2017 | 105 pages | ID: G3FC5617B55EN
QYResearch

Abstracts

This report studies the global Cancer Biological Therapy market, analyzes and researches the Cancer Biological Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• ELI Lilly
• Sanofi
• Merck
• Bayer
• Roche
• Novartis International
• Pfizer
• Bristol-Myers Squibb
• Seattle Genetics
• Amgen
• Takeda Pharmaceuticals
• GlaxoSmithKline
• Spectrum Pharmaceuticals
• Celgene Corporation
• AstraZeneca, Plc.
• Otsuka
• Eisai
• Abbvie
• Incyte

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Cancer Biological Therapy can be split into

• Monoclonal Antibodies
• Vaccines
• Cancer Growth Blockers
• Blood Cell Growth Factors

Market segment by Application, Cancer Biological Therapy can be split into

• Hospitals
• Diagnostic Laboratories
• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Cancer Biological Therapy Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF CANCER BIOLOGICAL THERAPY

1.1 Cancer Biological Therapy Market Overview
  1.1.1 Cancer Biological Therapy Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Cancer Biological Therapy Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Cancer Biological Therapy Market by Type
  1.3.1 Monoclonal Antibodies
  1.3.2 Vaccines
  1.3.3 Cancer Growth Blockers
  1.3.4 Blood Cell Growth Factors
1.4 Cancer Biological Therapy Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Diagnostic Laboratories
  1.4.3 Research & Academic Laboratories
  1.4.4 Pharmaceutical & Biotechnology Companies

2 GLOBAL CANCER BIOLOGICAL THERAPY COMPETITION ANALYSIS BY PLAYERS

2.1 Cancer Biological Therapy Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 ELI Lilly
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Sanofi
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Merck
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Bayer
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Roche
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novartis International
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Pfizer
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Bristol-Myers Squibb
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Seattle Genetics
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Amgen
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Cancer Biological Therapy Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Takeda Pharmaceuticals
3.12 GlaxoSmithKline
3.13 Spectrum Pharmaceuticals
3.14 Celgene Corporation
3.15 AstraZeneca, Plc.
3.16 Otsuka
3.17 Eisai
3.18 Abbvie
3.19 Incyte

4 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Cancer Biological Therapy Market Size by Type (2012-2017)
4.2 Global Cancer Biological Therapy Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Biological Therapy in Future
4.4 Top Consumer/End Users of Cancer Biological Therapy

5 UNITED STATES CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Cancer Biological Therapy Market Size (2012-2017)
5.2 United States Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

6 EU CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Cancer Biological Therapy Market Size (2012-2017)
6.2 EU Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

7 JAPAN CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Cancer Biological Therapy Market Size (2012-2017)
7.2 Japan Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

8 CHINA CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

8.1 China Cancer Biological Therapy Market Size (2012-2017)
8.2 China Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

9 INDIA CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

9.1 India Cancer Biological Therapy Market Size (2012-2017)
9.2 India Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA CANCER BIOLOGICAL THERAPY DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Cancer Biological Therapy Market Size (2012-2017)
10.2 Southeast Asia Cancer Biological Therapy Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Cancer Biological Therapy Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
  11.1.2 EU Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
  11.1.4 China Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
  11.1.5 India Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Cancer Biological Therapy Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Biological Therapy Market Size (Value) by Type (2017-2022)
11.3 Global Cancer Biological Therapy Market Size by Application (2017-2022)

12 CANCER BIOLOGICAL THERAPY MARKET DYNAMICS

12.1 Cancer Biological Therapy Market Opportunities
12.2 Cancer Biological Therapy Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Cancer Biological Therapy Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Cancer Biological Therapy Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Biological Therapy Product Scope
Figure Global Cancer Biological Therapy Market Size (Million USD) (2012-2017)
Table Global Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Biological Therapy Market Share by Regions in 2016
Figure United States Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Biological Therapy Market Share by Type in 2016
Figure Monoclonal Antibodies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Vaccines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Cancer Growth Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure Blood Cell Growth Factors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cancer Biological Therapy Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Cancer Biological Therapy Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Diagnostic Laboratories
Figure Cancer Biological Therapy Market Size (Million USD) and Growth Rate in Diagnostic Laboratories (2012-2017)
Table Key Downstream Customer in Research & Academic Laboratories
Figure Cancer Biological Therapy Market Size (Million USD) and Growth Rate in Research & Academic Laboratories (2012-2017)
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Cancer Biological Therapy Market Size (Million USD) and Growth Rate in Pharmaceutical & Biotechnology Companies (2012-2017)
Table Cancer Biological Therapy Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Biological Therapy Market Size Share by Players in 2016
Figure Cancer Biological Therapy Market Size Share by Players in 2017
Table ELI Lilly Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of ELI Lilly (2012-2017)
Figure ELI Lilly Cancer Biological Therapy Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Cancer Biological Therapy Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Cancer Biological Therapy Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Cancer Biological Therapy Business Revenue Market Share in 2016
Table Roche Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Roche (2012-2017)
Figure Roche Cancer Biological Therapy Business Revenue Market Share in 2016
Table Novartis International Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Novartis International (2012-2017)
Figure Novartis International Cancer Biological Therapy Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Cancer Biological Therapy Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Cancer Biological Therapy Business Revenue Market Share in 2016
Table Seattle Genetics Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Seattle Genetics (2012-2017)
Figure Seattle Genetics Cancer Biological Therapy Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Cancer Biological Therapy Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Cancer Biological Therapy Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Cancer Biological Therapy Business Revenue Market Share in 2016
Table Spectrum Pharmaceuticals Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Spectrum Pharmaceuticals (2012-2017)
Figure Spectrum Pharmaceuticals Cancer Biological Therapy Business Revenue Market Share in 2016
Table Celgene Corporation Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Celgene Corporation (2012-2017)
Figure Celgene Corporation Cancer Biological Therapy Business Revenue Market Share in 2016
Table AstraZeneca, Plc. Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of AstraZeneca, Plc. (2012-2017)
Figure AstraZeneca, Plc. Cancer Biological Therapy Business Revenue Market Share in 2016
Table Otsuka Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Otsuka (2012-2017)
Figure Otsuka Cancer Biological Therapy Business Revenue Market Share in 2016
Table Eisai Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Eisai (2012-2017)
Figure Eisai Cancer Biological Therapy Business Revenue Market Share in 2016
Table Abbvie Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Abbvie (2012-2017)
Figure Abbvie Cancer Biological Therapy Business Revenue Market Share in 2016
Table Incyte Basic Information List
Table Cancer Biological Therapy Business Revenue (Million USD) of Incyte (2012-2017)
Figure Incyte Cancer Biological Therapy Business Revenue Market Share in 2016
Table Global Cancer Biological Therapy Market Size (Million USD) by Type (2012-2017)
Figure Global Cancer Biological Therapy Market Size Share by Type in 2012
Figure Global Cancer Biological Therapy Market Size Share by Type in 2013
Figure Global Cancer Biological Therapy Market Size Share by Type in 2014
Figure Global Cancer Biological Therapy Market Size Share by Type in 2015
Figure Global Cancer Biological Therapy Market Size Share by Type in 2016
Figure Global Cancer Biological Therapy Market Size Share by Type in 2017
Table Global Cancer Biological Therapy Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2012
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2013
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2014
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2015
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2016
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Biological Therapy
Figure United States Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Biological Therapy Market Size Share by Players in 2016
Figure United States Cancer Biological Therapy Market Size Share by Players in 2017
Figure EU Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Biological Therapy Market Size Share by Players in 2016
Figure EU Cancer Biological Therapy Market Size Share by Players in 2017
Figure Japan Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Biological Therapy Market Size Share by Players in 2016
Figure Japan Cancer Biological Therapy Market Size Share by Players in 2017
Figure China Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Biological Therapy Market Size Share by Players in 2016
Figure China Cancer Biological Therapy Market Size Share by Players in 2017
Figure India Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Biological Therapy Market Size Share by Players in 2016
Figure India Cancer Biological Therapy Market Size Share by Players in 2017
Figure Southeast Asia Cancer Biological Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Biological Therapy Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Biological Therapy Market Size Share by Players in 2016
Figure Southeast Asia Cancer Biological Therapy Market Size Share by Players in 2017
Figure Global Cancer Biological Therapy Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Biological Therapy Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Biological Therapy Market Size Share by Regions in 2017
Figure Global Cancer Biological Therapy Market Size Share by Regions in 2022
Figure United States Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Biological Therapy Market Size (Million USD) by Type (2017-2022)
Figure Global Cancer Biological Therapy Market Size Share by Type in 2017
Figure Global Cancer Biological Therapy Market Size Share by Type in 2022
Table Global Cancer Biological Therapy Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2017
Figure Global Cancer Biological Therapy Market Size (Million USD) by Application in 2022